Ashley Kalinauskas

Entrepreneur-in-Residence

Ashley Kalinauskas is the founder and CEO of Torigen, a biotechnology company helping our furry best friends live longer, healthier lives. Their initial product, VetiVax, is a personalized cancer vaccine that was originally developed to move forward for human clinical studies, but was repositioned to help the millions of dogs, cats and horses after a cancer diagnosis. Ashley has grown the company from an idea on the scientific benchtop, to a company of over 30 employees poised to help grow the animal health industry.